Search Results - "SCHLIEMANN, C"

PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation by Albring, J C, Inselmann, S, Sauer, T, Schliemann, C, Altvater, B, Kailayangiri, S, Rössig, C, Hartmann, W, Knorrenschild, J R, Sohlbach, K, Groth, C, Lohoff, M, Neubauer, A, Berdel, W E, Burchert, A, Stelljes, M

Get full text

Outcome of allogeneic stem cell transplantation for AML and myelodysplastic syndrome in elderly patients (⩾60 years) by Pohlen, M, Groth, C, Sauer, T, Görlich, D, Mesters, R, Schliemann, C, Lenz, G, Müller-Tidow, C, Büchner, T, Berdel, W E, Stelljes, M

“…Allogeneic stem cell transplantation (SCT) remains the best curative option for patients with refractory AML or with high-risk myelodysplastic syndrome (MDS)…”
Get full text

Nivolumab in a patient with refractory Hodgkin’s lymphoma after allogeneic stem cell transplantation by Angenendt, L, Schliemann, C, Lutz, M, Rebber, E, Schulze, A B, Weckesser, M, Stegger, L, Schäfers, M, Groth, C, Kessler, T, Lenz, G, Stelljes, M, Berdel, W E

Get full text

Antibody-based targeting of the tumor vasculature by Schliemann, Christoph, Neri, Dario

“…Conventional cytotoxic therapies of cancer often suffer from a lack of specificity, leading to a poor therapeutic index and considerable toxicities to normal…”
Get full text

Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and Bone by Isfort, Ilka, Elges, Sandra, Cyra, Magdalene, Berthold, Ruth, Renner, Marcus, Mechtersheimer, Gunhild, Åman, Pierre, Larsson, Olle, Ratner, Nancy, Hafner, Susanne, Simmet, Thomas, Schliemann, Christoph, Rossig, Claudia, Dirksen, Uta, Grünewald, Inga, Wardelmann, Eva, Huss, Sebastian, Hartmann, Wolfgang, Trautmann, Marcel

“…Tumors of soft tissue and bone represent a heterogeneous group of neoplasias characterized by a wide variety of genetic aberrations. Albeit knowledge on…”
Get full text

Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours by Ahlskog, J K J, Schliemann, C, Mårlind, J, Qureshi, U, Ammar, A, Pedley, R B, Neri, D

“…Background: Hypoxia, which is commonly observed in areas of primary tumours and of metastases, influences response to treatment. However, its characterisation…”
Get full text

Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia by Krug, U, Berdel, W E, Gale, R P, Haferlach, C, Schnittger, S, Müller-Tidow, C, Braess, J, Spiekermann, K, Staib, P, Beelen, D, Serve, H, Schliemann, C, Stelljes, M, Balleisen, L, Maschmeyer, G, Grüneisen, A, Eimermacher, H, Giagounidis, A, Rasche, H, Hehlmann, R, Lengfelder, E, Thiel, E, Reichle, A, Aul, C, Ludwig, W-D, Kern, W, Haferlach, T, Köpcke, W, Görlich, D, Sauerland, M C, Heinecke, A, Wörmann, B J, Hiddemann, W, Büchner, T

“…We randomized 3375 adults with newly diagnosed acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome to test whether increasingly intensive…”
Get full text

An atlas of bloodstream-accessible bone marrow proteins for site-directed therapy of acute myeloid leukemia by Angenendt, L, Reuter, S, Kentrup, D, Benk, A S, Neumann, F, Hüve, J, Martens, A C, Schwöppe, C, Kessler, T, Schmidt, L H, Sauer, T, Brand, C, Mikesch, J-H, Lenz, G, Mesters, R M, Müller-Tidow, C, Hartmann, W, Wardelmann, E, Neri, D, Berdel, W E, Roesli, C, Schliemann, C

“…The concept of arming antibodies with bioactive payloads for a site-specific therapy of cancer has gained considerable interest in recent years. However, a…”
Get full text

P478: THE GERMLINE VARIANT GFI1‐36N PROMOTES GENETIC INSTABILITY IN LEUKEMIC CELLS AND OPENS NEW THERAPEUTIC APPROACHES FOR ABOUT 15% OF ALL AML PATIENTS by Vorwerk, J., Frank, D., Sun, K., Neumannn, F., Heuser, M., Kunadt, D., Berdel, W. E., Mikesch, J.‐H., Schliemann, C., Lenz, G., Jayavelu, A. K., Khandanpour, C.

Get full text

Use of palifermin for the prevention of high-dose methotrexate-induced oral mucositis by Schmidt, E., Thoennissen, N.H., Rudat, A., Bieker, R., Schliemann, C., Mesters, R.M., Zühlsdorf, M., Müller-Tidow, C., Berdel, W.E.

“…Oral mucositis is a frequent problem after high-dose methotrexate (HD-MTX), impairing patient's quality of life, leading to higher rates of infections and…”
Get full text

Bevacizumab reduces VEGF expression in patients with relapsed and refractory acute myeloid leukemia without clinical antileukemic activity by ZAHIRAGIC, L, SCHLIEMANN, C, BIEKER, R, THOENNISSEN, N. H, BUROW, K, KRAMER, C, ZÜHLSDORF, M, BERDEL, W. E, MESTERS, R. M

Get full text

Blood group antigen A type 3 expression is a favorable prognostic factor in advanced NSCLC by Schmidt, L.H, Kuemmel, A, Schliemann, C, Schulze, A, Humberg, J, Mohr, M, Görlich, D, Hartmann, W, Bröckling, S, Marra, A, Hillejan, L, Goletz, S, Karsten, U, Berdel, W.E, Spieker, T, Wiewrodt, R

“…Highlights • A type 3 is expressed on A1 erythrocytes and in NSCLC tissues of patients blood group A1. • No prognostic effect for A type 1/2 antigen. •…”
Get full text

P545: CHARACTERISTICS AND OUTCOME OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND TRISOMY 19 by Kayser, S., Martínez‐Cuadrón, D., Rodriguez‐Veiga, R., Hänel, M., Tormo, M., Schäfer‐Eckart, K., Botella, C., Stölzel, F., Bernal del Castillo, T., Keller, U., Rodriguez‐Medina, C., Held, G., Amigo, M.‐L., Schliemann, C., Colorado, M., Kaufmann, M., Barrios Garcia, M., Krause, S. W., Görner, M., Jost, E., Steffen, B., Ho, A. D., Baldus, C., Serve, H., Platzbecker, U., Müller‐Tidow, C., Thiede, C., Bornhäuser, M., Montesinos, P., Röllig, C., Schlenk, R. F.

Get full text

P555: A PHASE 1B/2 STUDY OF THE CD123‐TARGETING ANTIBODY‐DRUG CONJUGATE PIVEKIMAB SUNIRINE (IMGN632) IN COMBINATION WITH VENETOCLAX (VEN) AND AZACITIDINE (AZA) FOR PATIENTS WITH CD123‐POSITIVE AML by Daver, N. G., Montesinos, P., Aribi, A., Martinelli, G., Altman, J., Roboz, G., Wang, E. S., Burke, P. W., Jeyakumar, D., Walter, R. B., DeAngelo, D. J., Erba, H. P., Advani, A., Gastaud, L., Thomas, X., Todisco, E., Pemmaraju, N., Mendez, L., Fuente, A., Gaidano, G., Curti, A., Boissel, N., Recher, C., Schliemann, C., Vyas, P., Sloss, C. M., Wang, J., Malcolm, K. A., Zweidler‐McKay, P. A., Sweet, K. L.

Get full text

Circulating angiopoietin-2 is a strong prognostic factor in acute myeloid leukemia by SCHLIEMANN, C, BIEKER, R, THOENNISSEN, N, GERSS, J, LIERSCH, R, KESSLER, T, BÜCHNER, T, BERDEL, W. E, MESTERS, R. M

“…Angiogenesis plays an important role in solid tumors and hematologic malignancies. The angiopoietins act as essential regulators in this process. We…”
Get full text

Correlation of neuropilin-1 overexpression to survival in acute myeloid leukemia by KREUTER, M, WOELKE, K, BIEKER, R, SCHLIEMANN, C, STEINS, M, BUECHNER, T, BERDEL, W. E, MESTERS, R. M

“…Neuropilin-1 (NRP-1), a vascular endothelial growth factors and semaphorin receptor functioning as mediator of angiogenesis and neuronal guidance, is expressed…”
Get full text

MN1–Fli1 oncofusion transforms murine hematopoietic progenitor cells into acute megakaryoblastic leukemia cells by Wenge, D V, Felipe-Fumero, E, Angenendt, L, Schliemann, C, Schmidt, E, Schmidt, L H, Thiede, C, Ehninger, G, Berdel, W E, Arteaga, M-F, Mikesch, J-H

“…Long-term outcome of acute megakaryoblastic leukemia (AMKL) patients without Down’s syndrome remains poor. Founding mutations and chimeric oncogenes…”
Get full text

Chemotherapy in metastatic malignant triton tumor: Report on two cases by THOENNISSEN, N. H, SCHLIEMANN, C, BERDEL, W. E, BRUNNBERG, U, SCHMIDT, E, STAEBLER, A, STEGGER, L, BREMER, C, SCHLEICHER, C, MESTERS, R. M, MÜLLER-TIDOW, C

“…Malignant triton tumor (MTT) is a rare, highly malignant nerve sheath tumor with rhabdomyoblastic differentiation. Initial debulking surgery followed by…”
Get full text

Amsacrine containing induction therapy in elderly AML patients: Comparison to standard induction regimens in a matched-pair analysis by Kessler, T, Mohr, M, Müller-Tidow, C, Krug, U, Brunnberg, U, Mohr, B, Schliemann, C, Sauerland, C, Serve, H, Büchner, T, Berdel, W.E, Mesters, R.M

“…Abstract Many elderly patients with newly diagnosed acute myeloid leukemia (AML) present with cardiac comorbidity precluding the use of anthracycline…”
Get full text

Solitary plasmacytoma of the lung with coexisting sarcoid-like lesions by Thoennissen, N. H., Schliemann, C., Hungermann, D., Bremer, J., Juergens, K. U., Semik, M., Müller-Tidow, C., Zuehlsdorf, M., Berdel, W. E.

Get full text